Shares Magazine
|
|
Glaxosmithkline PLC = |
|
Buys |
|
Sells |
Click on a deal for more details.
Glaxosmithkline Director Holdings
| Name | Position | Appointed | Last Deal | Total % | Shares Held | Total Value (£) |
|---|---|---|---|---|---|---|
| Sir Roy Anderson | Non Executive Director | 2007 | 26/04/18 | na | 235,879 | 3,935,877 |
| Manvinder Banga | Non Executive Director | 2015 | 05/02/20 | na | 5,225 | 87,184 |
| Dr Hal Barron | Executive Director | 2018 | na | na | na | |
| Dr Vivienne Cox | Non Executive Director | 2016 | 05/02/20 | na | 5,009 | 83,580 |
| Lynn Elsenhans | Non Executive Director | 2012 | na | 55,360 | 923,737 | |
| Dr Laurie Glimcher | Non Executive Director | 2017 | na | 7,249 | 120,957 | |
| Dr Jesse Goodman | Non Executive Director | 2016 | na | 6,981 | 116,485 | |
| Judy Lewent | Non Executive Director | 2011 | 02/01/13 | na | 45,210 | 754,374 |
| Iain Mackay | Executive Director | 2019 | na | na | na | |
| Urs Rohner | Non Executive Director | 2015 | 05/02/20 | na | 9,499 | 158,500 |
| Jonathan Symonds | Chairman | 2019 | 06/02/20 | na | 14,995 | 250,207 |
| Emma Walmsley | Chief Executive Officer | 2017 | 15/01/20 | na | 717,227 | 11,967,650 |
Glaxosmithkline Director Deals
Set up a new alert »| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|---|---|---|---|---|
| 06/02/20 | BUY | Jonathan Symonds | CH | 11,730 @ 1,705.00p | £199,996 |
| 05/02/20 | BUY | Urs Rohner | NED | 399 @ 1,800.00p | £7,182 |
| 05/02/20 | LOF | Manvinder Banga | NED | 399 @ 1,800.00p | £7,182 |
| 05/02/20 | LOF | Dr Vivienne Cox | NED | 295 @ 1,800.00p | £5,310 |
| 05/02/20 | LOF | Jonathan Symonds | CH | 2,431 @ 1,800.00p | £43,758 |
| 15/01/20 | DRI | Emma Walmsley | CEO | 1,754 @ 1,790.20p | £31,400 |
| 14/01/20 | BUY | Emma Walmsley | CEO | 1,371 @ 1,800.83p | £24,689 |
| 01/11/19 | EXR | Emma Walmsley | CEO | 137,040 @ 1,203.50p | £1,649,276 |
| 01/11/19 | SEXR | Emma Walmsley | CEO | 112,945 @ 1,775.88p | £2,005,768 |
| 30/10/19 | BUY | Manvinder Banga | NED | 417 @ 1,725.00p | £7,193 |
| 30/10/19 | BUY | Dr Vivienne Cox | NED | 308 @ 1,725.00p | £5,313 |
| 30/10/19 | BUY | Jonathan Symonds | CH | 834 @ 1,725.00p | £14,386 |
| 15/10/19 | BUY | Emma Walmsley | CEO | 1,470 @ 1,660.32p | £24,407 |
| 15/10/19 | DRI | Emma Walmsley | CEO | 1,815 @ 1,712.00p | £31,073 |
| 26/09/19 | TIN | Emma Walmsley | CEO | 10,668 @ 1,685.80p | £179,841 |
| 24/07/19 | BUY | Sir Philip Hampton | RES | 2,645 @ 1,654.00p | £43,748 |
| 24/07/19 | BUY | Urs Rohner | NED | 548 @ 1,654.00p | £9,064 |
| 24/07/19 | BUY | Manvinder Banga | NED | 548 @ 1,654.00p | £9,064 |
| 24/07/19 | BUY | Dr Vivienne Cox | NED | 435 @ 1,654.00p | £7,195 |
| 15/07/19 | DRIP | Emma Walmsley | CEO | 1,881 @ 1,632.40p | £30,705 |
Sign up to our
daily email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
